AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 OCT 7 - (NewsRx.com & NewsRx.net) -- Doctors may soon have a new tool - a noninvasive, painless nipple fluid test - in their fight to make breast cancer a more treatable, nonfatal disease.
Within the next couple years, women will be able to go for a routine check-up and receive the test - currently in development at IMI International Medical Innovations - that can detect breast cancer in its early, most treatable stage. IMI's breast cancer test identifies a cancer-associated sugar in a sample of nipple aspirate fluid derived from the breast ducts and painlessly expressed through the nipple using a pump.
"Most breast cancers originate in the breast ducts, so nipple aspirate fluid is a logical sample to target," said Dr. Anees Chagpar, an assistant professor in the division of surgical oncology, University of Louisville (Kentucky). "The early results we have seen with this test are promising, and we are planning additional studies to confirm and expand our ...
Source: HighBeam Research, New test discovers breast cancer at early, most treatable stage.